The Effects of a Combination of TeaCrine®, Dynamine, and Caffeine in Law Enforcement

• Status: Completed
• Trial end date: 2020-11-15
• Target enrollment: 0
• Participant gender: Male

Summary

The purpose of this randomized, placebo-controlled, three-condition, double-blind, between-subjects clinical trial is to determine and compare the effects of the combination of TeaCrine®, Dynamine, and caffeine to a placebo and caffeine condition on reaction time and target acquisition and accuracy. A secondary purpose is to observe the changes in hemodynamic variables in response to this combination.

• Phase: Early Phase 1
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Rutgers, The State University of New Jersey; University of South Carolina
• Collaborators: Compound Solutions Inc.; Rutgers, The State University of New Jersey
• Treatments: Caffeine

Criteria

Inclusion Criteria:

• Subject has provided written and dated informed consent to participate in the study.

• Subject is in good health as determined by physical examination and medical history.

• Subject is between the ages of 18 and 63.

• Subject is a current member of the military or law enforcement.

Exclusion Criteria:

• Subjects who have injuries that would prevent them from completing the protocol.

• Subjects who have migraine headaches.

• Subjects with a history of kidney or liver disease.

• Subjects with a history of caffeine sensitivity.

• Subjects currently taking OTC products containing pseudoephedrine or other stimulants.

• Subjects who drink more than four cups of coffee per day.